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Uric acid examination i 554 epileptic out-patients under long-term anticonvulsant medication revealed significantly lower serum 
concentrations compared to a group of normal controls. In patients taking enzyme-inducing drugs, uric acid levels were found to be 
lower than in those under valproate sodium. In addition, uric acid concentrations showed anegative correlation with duration of thera- 
py in epileptic males. At this time, we can only speculate on the mechanism involved in the reduction of uric acid by enzyme-inducing 
anticonvulsants as well as on the possible implication of this finding in the treatment of hyperuricemia. 
INTRODUCTION 
Investigations on the possible influence of long- 
term anticonvulsant medication on the serum con- 
centration of uric acid have scarcely been done. In 
their survey of side-effects of anticonvulsants Mei- 
nardi and Stoel 2 only mention the possibility of hy- 
peruricemia under carbamazepine therapy. 
method by one of us (B.S.) 1. Uric acid concentra- 
tions of patients under monotherapy with pheny- 
toin, carbamazepine, primidone, or valproate so- 
dium for at least 1 year before examination were 
compared using the Kruskal-Wallis test. Subse- 
quently, the uric acid levels of the epileptics were 
correlated (Spearman's rank correlation coeffi- 
cient) with duration of therapy according to sex. 
PATIENTS AND METHODS RESULTS 
We examined 554 epileptic out-patients (326 
males, 228 females, aged 20-40) treated with anti- 
convulsants for more than 1 year. Uric acid in se- 
rum was measured by applying a standard colori- 
metric method using phosphotungsten (Autoana- 
lyzer System SMA 12/60). The Wilcoxon test 
served to compare the concentrations obtained to 
those of a normal population (787 males, 748 fe- 
males) of the same age and living in the Heidel- 
berg area, that had been examined with the same 
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Mean values and standard eviations were 4.7 + 
1.4 mg/dl in epileptic males and 3.5 + 1.1 in epilep- 
tic females, both differing (P < 0.0001) in Wilcox- 
on test from those of the control group (6.4 + 1.1 
in males and 4.5 + 0.8 in females). The frequency 
distributions are given in Figs. 1 and 2. In the 
group under valproate sodium uric acid concentra- 
tions were higher (mean + S.D., 5.7 + 1.3 mg/dl in 
males (n = 25), 4.2 + 1.5 in females (n = 14)) than 
in the groups taking phenytoin (4.4 + 1.1 in males 
(n = 28), 3.4 + 1.1 in females (n = 23)), primidone 
(5.1 + 1.2 in males (n = 50), 3.4 + 0.8 in females 
(n = 29)), or carbamazepine (4.1 + 1.3 in males 
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Fig. 1. Frequency distribution of uric acid in serum of epileptic 
males (1) and male controls (2). 
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Fig. 2. Frequency distribution of uric acid in serum of epileptic 
females (1) and female controls (2). 
(n = 24), 3.1 + 0.9 in females (n = 30)) (Fig. 3). 
According to the Kruskal-Wallis test, the differ- 
ences between the epileptics under valproate sodi- 
um and those under other anticonvulsants were 
significant for both sexes (P = 0.0001 in males and 
P = 0.0389 in females). The uric acid serum levels 
in male epileptics howed a negative correlation 
with duration of therapy (P < 0.01). 
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Fig. 3. Uric acid in serum (mg/dl) of male and female pileptics 
under monotherapy with phenytoin (PHT), primidone (PRM), 
carbamazepine (CBZ), or valproate sodium (VPA) (mean _+ 
S.D., [] = median). 
DISCUSSION 
Our findings uggest that long-term antiepileptic 
medication has an influence on serum uric acid, re- 
suiting in lower concentrations. The pathogenic 
mechanism is not clear; but our data show that es- 
pecially antiepileptic drugs with enzyme-inducing 
properties (phenytoin, carbamazepine, primi- 
done) 3 are effective, as has been reported for bili- 
rubin reduction 4.Thus, we postulate that accelera- 
tion of protein synthesis, caused by enzyme-induc- 
ing properties of anticonvulsants, may lead to low- 
er uric acid serum levels. The possible influence of 
anticonvulsants on uric acid could be of value in 
the treatment of hyperuricemia. 
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